Rare Medical Case Reveals Semen Allergy as a Potential Factor in Unexplained Infertility and Failed IVF Procedures

The journey toward parenthood is often paved with emotional and physical challenges, typically involving well-known factors such as hormonal imbalances, polycystic ovary syndrome (PCOS), endometriosis, or low sperm motility. However, a recent case study published in medical literature and highlighted by Live Science has brought to light an extraordinarily rare and often overlooked barrier to conception: Human Seminal Plasma Hypersensitivity (HSPA), commonly known as a semen allergy. A 29-year-old woman in Lithuania recently became the focus of medical scrutiny after her struggle with "unexplained" infertility led to the discovery that her own immune system was reacting aggressively to her partner’s seminal fluid, potentially sabotaging her chances of pregnancy even through advanced reproductive technologies like In Vitro Fertilization (IVF).

The Clinical Presentation and Patient History

The patient, a 29-year-old female whose identity remains confidential, sought medical intervention after years of failing to conceive naturally. Her medical history was notable for several pre-existing conditions that suggested a highly reactive immune system. She suffered from chronic asthma and had a documented history of sensitivities to various environmental allergens, including mold, dust mites, and animal dander.

Despite these underlying allergic conditions, her primary concern was her inability to achieve pregnancy. Before the allergy was identified, she had already undergone two full cycles of In Vitro Fertilization (IVF). IVF is generally considered the "gold standard" for overcoming infertility, as it bypasses many traditional barriers by fertilizing the egg in a laboratory setting and then transferring the embryo directly into the uterus. When both cycles failed to result in a viable pregnancy, doctors were left searching for answers, as standard gynecological examinations and fertility screenings showed no anatomical or hormonal abnormalities that would prevent a successful gestation.

A Breakthrough in Diagnosis: The Link Between Dogs and Semen

The turning point in the case occurred when the patient visited an allergy specialist to determine if her systemic allergies were somehow interfering with her reproductive health. Initial blood work revealed a significantly elevated level of eosinophils—a specialized type of white blood cell that the body produces in response to allergic reactions, infections, or parasites. High eosinophil counts are a hallmark of an overactive immune response.

Subsequent skin prick tests confirmed that the woman was highly sensitive to a variety of triggers, including pollen, certain insects, and dogs. Specifically, she tested positive for a sensitivity to a protein known as Canis familiaris allergen 5 (Can f 5). This protein is primarily found in the urine and dander of male dogs.

The medical team noted a crucial biological parallel: the Can f 5 protein shares structural similarities with human prostate-specific antigen (PSA), a protein found in human seminal plasma. This phenomenon, known as cross-reactivity, occurs when the immune system mistakes one protein for another due to their similar molecular structures. "Sensitivities to Can f 5 can indicate a cross-sensitivity to similar proteins found in human semen," the reporting physicians noted. This revelation prompted the doctors to ask the patient about her physical reactions following unprotected intercourse.

Recognizing Overlooked Symptoms

Upon further questioning, the patient admitted that she frequently experienced nasal congestion, sneezing, and respiratory discomfort immediately following unprotected sexual contact with her partner. For years, these symptoms had been dismissed or ignored by both the patient and previous medical consultants, as they were perceived as minor or unrelated to the primary issue of infertility.

To confirm the diagnosis, the medical team performed a localized allergy test using a sample of her partner’s seminal plasma. The test yielded a definitive positive result, confirming that the woman was suffering from Human Seminal Plasma Hypersensitivity. While the allergy is directed at the fluid (plasma) that carries the sperm, rather than the sperm cells themselves, the resulting immune response can have devastating effects on the reproductive environment.

The Science of HSPA and Its Impact on Fertility

Human Seminal Plasma Hypersensitivity is a rare allergic reaction to proteins found in a man’s semen. While the exact prevalence is difficult to determine because many cases likely go unreported or misdiagnosed, medical literature has only documented approximately 80 major cases worldwide.

In a typical allergic reaction, the body identifies a harmless substance as a threat and releases IgE antibodies, which trigger the release of chemicals like histamine. In the context of the female reproductive tract, this allergic reaction can cause localized inflammation, known as vaginitis or vulvovaginitis, but it can also have systemic effects.

The relationship between HSPA and infertility is a subject of ongoing research. Experts suggest that the inflammatory environment created by the allergic reaction may be hostile to sperm, making it difficult for them to survive long enough to reach the egg. Furthermore, chronic inflammation in the lining of the uterus (endometrium) or the fallopian tubes can interfere with the implantation of a fertilized egg.

In the case of the Lithuanian patient, the failure of two IVF cycles was particularly perplexing because IVF involves transferring an embryo that is no longer in contact with seminal plasma. However, the medical report suggested that the systemic immune activation and localized inflammation caused by the allergy might have created an "inhospitable" environment for the embryo to latch onto the uterine wall.

Challenges in Treatment and Management

The management of semen allergy presents a unique challenge, especially for couples who are actively trying to conceive. The most effective way to prevent the allergic reaction is the use of condoms, which prevents the seminal fluid from coming into contact with the woman’s mucosal membranes. However, this method is obviously counterproductive for those seeking natural conception.

There are two primary medical approaches to treating HSPA for couples wanting to get pregnant:

1. Intravaginal or Subcutaneous Desensitization: This involves exposing the patient to small, gradually increasing amounts of the partner’s semen or purified seminal proteins over several hours or weeks. The goal is to "train" the immune system to tolerate the allergen. Unfortunately, the medical report noted that this specialized treatment was not available in Lithuania at the time of the patient’s diagnosis.
2. Antihistamine Therapy: Doctors recommended that the patient take high-dose antihistamines prior to intercourse to dampen the allergic response. However, the patient reported that this approach was "ineffective" in mitigating her symptoms or helping her achieve pregnancy.

During a follow-up visit three years after the initial diagnosis, the patient’s condition appeared to have worsened. She reported that her symptoms had progressed from respiratory issues to more severe localized and systemic reactions, including a burning sensation in the vulva, swelling of the eyelids (angioedema), and watery eyes following exposure. Despite the diagnosis, she remained unable to conceive, and no further effective treatments were available within her local healthcare system.

Broader Implications for Reproductive Medicine

This rare case underscores the necessity of a multidisciplinary approach to infertility. When "unexplained infertility" is diagnosed, it often means that the cause simply hasn’t been found yet. The Lithuanian case suggests that allergy screenings, particularly for women with a history of asthma or multiple environmental sensitivities, should perhaps be considered when traditional fertility treatments fail.

The cross-reactivity between dog allergens (Can f 5) and human semen is a particularly significant finding for the medical community. It provides a specific diagnostic marker that could help identify at-risk women before they undergo the emotional and financial strain of multiple failed IVF cycles.

Furthermore, the case highlights the gendered aspect of medical diagnosis, where symptoms like sneezing or congestion following intercourse are often overlooked or attributed to "post-coital rhinitis" without investigating a more serious underlying immunological cause.

Conclusion and Future Outlook

The story of the 29-year-old woman in Lithuania serves as a cautionary tale and a call for increased awareness within the field of reproductive immunology. While Human Seminal Plasma Hypersensitivity remains a rare diagnosis, its impact on those it affects is profound, often leading to years of heartbreak and medical frustration.

For the medical community, the case emphasizes that the human body is an interconnected system where the immune system and the reproductive system are in constant dialogue. As research continues into the 80 documented cases worldwide, there is hope that more standardized treatments—such as "washed sperm" intrauterine insemination (IUI), where the allergenic plasma is removed before the sperm is inserted—will become more widely recognized and available as a solution for HSPA-related infertility.

For now, the Lithuanian case remains a poignant reminder of the complexities of human biology and the need for doctors to listen closely to the subtle, seemingly unrelated symptoms patients report. As medical technology advances, the goal remains to turn "unexplained" hurdles into treatable conditions, offering hope to couples who find themselves on the rare end of the medical spectrum.